7LBA Safety, activity, and response durability assessment of single agent rovalpituzumab tesirine, a delta-like protein 3 (DLL3)-targeted antibody drug conjugate (ADC), in small cell lung cancer (SCLC)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Pietanza, MC; Spigel, D; Bauer, TM; Ready, NE; Glisson, BS; Morgensztern, D; Robert, F; Salgia, R; Kochendorfer, M; Patel, M; Strickland, DK; Govindan, R; Burris, HA; Rudin, CM; Dylla, S

Published Date

  • September 2015

Published In

Volume / Issue

  • 51 /

Start / End Page

  • S712 - S712

Published By

International Standard Serial Number (ISSN)

  • 0959-8049

Digital Object Identifier (DOI)

  • 10.1016/s0959-8049(16)31931-1